Top Markets
Coin of the day
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

BSPM
Rank in Stocks #42724
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$264.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade Biostar Pharmaceuticals, Inc. (BSPM)

Category

Price of BSPM with the market cap of B
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
BSPM
$0.0001
Market Capitalization of Biostar Pharmaceuticals, Inc.(BSPM)
Market Cap: $264.00
As of August 2026 Biostar Pharmaceuticals, Inc. has a market cap of $264.00. This makes Biostar Pharmaceuticals, Inc. the world's 42724th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Biostar Pharmaceuticals, Inc. from 2008 to 2026
BSPM compared with Top 5 Most Popular stocks
Price of BSPM Asset B Mkt. of B Results
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$2,055,299 $264.00
$5.426T +2,055,298,683,037.50%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,680,645 $264.00
$4.437T +1,680,645,217,339.39%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,571,737 $264.00
$4.149T +1,571,737,275,416.29%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,387,818 $264.00
$3.664T +1,387,818,418,650.00%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,094,413 $264.00
$2.889T +1,094,412,685,127.27%